Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

TrivarX Ltd

Healthcare AU TRI

0.01AUD
-(-%)

Last update at 2025-06-19T04:54:00Z

Day Range

0.0090.01
LowHigh

52 Week Range

0.0090.04
LowHigh

Fundamentals

  • Previous Close 0.01
  • Market Cap6.20M
  • Volume1280629
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.34090M
  • Revenue TTM2.00M
  • Revenue Per Share TTM0.005
  • Gross Profit TTM 1.98M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -3.11970M -12.71581M -1.48660M -3.87240M -6.58704M
Minority interest - - - - -
Net income -3.11970M -12.72450M -2.65573M -4.70086M -6.58704M
Selling general administrative 0.75M 1.41M 1.19M 1.87M 4.54M
Selling and marketing expenses 0.08M 0.02M 0.00709M 0.00092M 0.12M
Gross profit 0.02M 0.04M -0.06904M -0.07119M 0.14M
Reconciled depreciation 0.54M 0.45M 0.20M 0.15M -
Ebit -1.78834M -2.67050M -1.48031M -3.83572M -6.72198M
Ebitda -1.24731M -2.22165M -1.28179M -3.68685M -6.57311M
Depreciation and amortization 0.54M 0.45M 0.20M 0.15M 0.15M
Non operating income net other - - - - -
Operating income -1.78834M -2.67050M -1.48031M -3.83572M -6.57311M
Other operating expenses 2.75M 3.68M 2.74M 4.77M 10.71M
Interest expense 0.01M 0.00869M 0.00629M 0.04M 0.01M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.01M 0.00869M 0.02M 0.04M 0.01M
Net interest income -0.01326M -0.00869M -0.01495M -0.03669M 0.02M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.95M 0.00869M 1.17M 0.83M -0.14886M
Total revenue 0.02M 0.04M 0.10M 0.13M 0.36M
Total operating expenses 2.75M 3.68M 2.57M 4.56M 10.48M
Cost of revenue 0.00016M 0.00107M 0.17M 0.20M 0.23M
Total other income expense net -0.37642M -10.04531M -0.00629M -0.03669M -0.01393M
Discontinued operations - - - - -
Net income from continuing ops -3.11970M -12.71581M -1.48660M -3.87240M -6.58704M
Net income applicable to common shares -3.11970M -12.71581M -1.48660M -3.87240M -6.58704M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 11.07M 8.06M 8.49M 17.38M 14.01M
Intangible assets 10.13M 7.63M 7.21M 14.69M 13.00M
Earning assets - - - - -
Other current assets 0.07M 0.09M 0.17M 0.32M 0.02M
Total liab 1.17M 1.76M 1.38M 0.96M 1.40M
Total stockholder equity 9.89M 6.30M 7.11M 16.42M 12.61M
Deferred long term liab - 2.47M 2.01M 4.38M 3.28M
Other current liab 0.16M 0.13M 0.31M 0.04M 0.12M
Common stock - 101.80M 99.45M 96.07M 91.67M
Capital stock 106.58M 101.80M 99.45M 96.07M 91.67M
Retained earnings -102.96889M -101.70504M -98.58534M -85.86953M -84.38293M
Other liab - - - - -
Good will - - - - -
Other assets - 0.02M 2.02M 4.39M 3.36M
Cash 0.85M 0.21M 1.03M 2.31M 0.81M
Cash and equivalents - - - - -
Total current liabilities 1.17M 1.76M 1.38M 0.96M 1.40M
Current deferred revenue - 0.14M - 0.13M -
Net debt - -0.11041M -0.96615M -2.28674M -0.73560M
Short term debt - 0.10M 0.07M 0.02M 0.08M
Short long term debt - - - - -
Short long term debt total - 0.10M 0.07M 0.02M 0.08M
Other stockholder equity - 6.20M 6.24M 6.22M 5.32M
Property plant equipment - 0.11M 0.07M 0.02M 0.07M
Total current assets 0.92M 0.30M 1.20M 2.66M 0.86M
Long term investments - - - - -
Net tangible assets - 1.18M 1.90M 6.11M 2.89M
Short term investments - - - - -
Net receivables - - - 0.03M 0.03M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.94M 1.38M 1.00M 0.76M 1.20M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 6.20M 6.24M 6.22M 5.32M
Additional paid in capital - - - - -
Common stock total equity - - - - 91.67M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.00767M 0.02M 0.01M 0.00676M 0.08M
Deferred long term asset charges - - - - -
Non current assets total 10.15M 7.75M 7.29M 14.72M 13.15M
Capital lease obligations 0.02M 0.10M 0.07M 0.02M 0.08M
Long term debt total - 0.00000M 0.00000M 0.00000M 0.00000M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -2.25867M -3.10955M -1.83196M -1.50495M -1.08503M
Change to liabilities 0.26M 0.39M -0.44343M -0.60416M -1.86056M
Total cashflows from investing activities -2.25867M -3.10955M -1.83196M -1.50495M -1.05721M
Net borrowings -0.04000M -0.04495M -0.05209M -0.15463M 2.34M
Total cash from financing activities 2.47M 3.33M 4.92M 4.55M 3.12M
Change to operating activities -0.02501M 0.26M -0.22252M 0.15M -0.93735M
Net income -3.11970M -12.72450M -1.49289M -3.90909M -6.58704M
Change in cash -0.81845M -1.27899M 1.50M -0.52059M -4.79010M
Begin period cash flow 1.03M 2.31M 0.81M 1.33M 6.12M
End period cash flow 0.21M 1.03M 2.31M 0.81M 1.33M
Total cash from operating activities -0.93208M -12.27564M -1.70089M -3.58882M -6.84901M
Issuance of capital stock 2.51M 3.38M 4.97M 4.71M 0.92M
Depreciation 0.10M 0.45M 0.20M 0.15M 0.15M
Other cashflows from investing activities 0.00000M 0.00000M 0.00133M 0.04M 0.05M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - 0.02M 0.00035M -0.01763M 1.65M
Sale purchase of stock 2.51M 3.38M 4.97M - -0.14088M
Other cashflows from financing activities -0.04000M -0.04495M -0.05209M -0.15463M 2.34M
Change to netincome 1.36M 10.61M 0.25M 0.60M 0.87M
Capital expenditures 2.26M 3.11M 1.83M 1.54M 1.14M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.94M 0.97M 1.12M 0.67M 3.15M
Stock based compensation - - - - -
Other non cash items - 12.28M 1.29M 3.72M 6.59M
Free cash flow -3.19075M -15.38519M -3.53417M -5.13029M -7.98805M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TRI
TrivarX Ltd 		- -% 0.01 - - 3.11 0.54 79.57 -0.3188
PME
Pro Medicus Ltd		 -2.68 0.97% 274.08 303.33 166.67 157.93 133.24 159.52 209.59
CGS
CogState Ltd		 -0.02 1.44% 1.37 23.92 19.34 5.13 3.19 2.25 8.27
ONE
Oneview Healthcare PLC		 -0.01 3.57% 0.27 - - 22.77 9.70 11.71 -3.5247
ALC
Alcidion Group Ltd		 - -% 0.09 - 43.29 3.47 1.45 3.29 53.70

Reports Covered

Stock Research & News

View All

Profile

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.

TrivarX Ltd

647 Beaufort Street, Mount Lawley, WA, Australia, 6050

Key Executives

Name Title Year Born
Dr. Thomas R. Young M.D. Chief Exec. Officer NA
Ms. Renee Stanton-Horne Operations & Account Mang. NA
Ms. Stephanie Ottens Investor Relations Director NA
Mr. Josh Purdy PR Director NA
Dr. Michael Player Head of Research NA
Dr. Matthew Flax Head of Algorithm Devel. Team NA
Mr. Archie Defillo M.D. Chief Medical Officer NA
Ms. Jennifer Solitario Sr. VP of Corp. Health NA
Mr. Massimiliano Grassi Head of Artificial Intelligence NA
Mr. Mathew Watkins C.A. Company Sec. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.